The risk of premalignant and malignant pathology in endometrial polyps

Acta Obstetricia et Gynecologica Scandinavica

Volumn 79, Issue 4, 2000, Pages 317-320

  Bakour, Shagaf H ^a   Khan, Khalid S ^a,b   Gupta, Janesh K ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Endometrial cancer; Endometrial polyps; Hysteroscopy

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTEROSCOPY; MAJOR CLINICAL STUDY; POLYP; PRIORITY JOURNAL; RISK ASSESSMENT; UTERUS BLEEDING;

COHORT STUDIES; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; POLYPS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; RISK ASSESSMENT; UTERINE DISEASES; UTERINE HEMORRHAGE;

EID: 0034063302     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2000.079004317.x     Document Type: Article

References (20)

1. Ben-Yehuda OM, Kim YB, Leuchter RS. Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma? Gynecol Oncol 1998; 68: 4-9.
2. Maja Jr H, Barbosa IC, Marques D, Calmon LC, Ladipo LC, Coutinho EM. Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy. J Am Assoc Gynecol Laparosc 1996; 4: 13-18.
3. Maja Jr H, Barbosa IC, Farias JP, Ladipo OA, Coutinho EM. Evaluation of the endometrial cavity during menopause. Int J Gynaecol Obstet 1996; 52: 61-6.
4. Cicinelli E, Comi N, Scorcia P, Petrizzo O, Epifani S. Hysteroscopy for diagnosis and treatment of endometrial adenocarcinoma precursors. Eur J Gynaecol Oncol 1993; 5: 425-36.
5. Bakour SH, Dwarakanath LS, Khan KS, Newton JR. The diagnostic accuracy of outpatient miniature hysteroscopy in predicting premalignant and malignant endometrial lesions. Gynaecol Endosc 1999; 8 (3): 143-8.
6. Gimpleson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. Am J Obstet Gynecol 1988; 158: 489-92.
7. Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. Am J Obstet Gynecol 1996; 174: 1678-82.
8. Haller H, Matejcic N, Rukavina B, Krasevic M, Rupcic S, Mozetic D. Transvaginal sonography and hysteroscopy in women with postmenopausal bleeding. Int J Gynaecol Obstet 1996; 54: 155-9.
9. Loffer FD. Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding the value of a negative hysteroscopic view. Obstet Gynecol 1989; 73: 16-20.
10. Saidi MH, Sadler RK, Theis VD, Akright BD, Farhat SA, Villanueva GR. Comparison of sonography, sonohysterography, and hysteroscopy for evaluation of abnormal uterine bleeding. J Ultrasound Med 1997; 16: 587-91.
11. Valle RF. Hysteroscopic evaluation of patients with abnormal uterine bleeding. Surg Gynecol Obstet 1981; 153: 521-6.
12. Bakour SH, Khan KS, Gupta JK, Newton JR. The diagnostic accuracy of ultrasound scan in predicting endometrial hyperplasia or cancer in postmenopausal bleeding. Acta Obstet Gynecol Scand 1999; 78(5): 447-51.
13. Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol 1991; 77: 954-6.
14. Cheng W-F, Lin H-H, Trong P-L, Huang S-C. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 1997; 66: 233-7.
15. Ismail MS. The effects of tamoxifen on the uterus. Curr Opin Obstet Gynecol 1996; 8: 27-31.
16. Exacoustos C, Zupi E, Chiaretti M, Arduini D, Romanini C. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Ultrasound Obstet Gynecol 1995; 6: 435-42.
17. Cohen I, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras MM et al. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 1993; 100: 567-70.
18. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometria; changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993; 81: 660-4.
19. Hardell L. Tamoxifen as risk factor for carcinoma of corpus uteri (letter). Lancet 1988; 3: 563.
20. Powles TJ, Bourne T, Athanasiou S, Chang J, Grubock K, Ashley S et al. The effect of norethisterone on endometrial abnormalities is identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Br J Cancer 1998; 78: 272-5.